PPT-Insulin/GLP-1 Agonist Combinations

Program Overview Pathophysiology of Hyperglycemia Updated ADAEASD Standard of Care 2017 Delays in Intensification of Therapy The Role of Basal Insulin and GLP1 RA in Controlling Hyperglycemia. Hanging Baskets. We are pleased to share with you our top 20 combinations for. Spring 2013. Out of over 60 combinations these are the top picks from industry brokers, growers, and over 300 home gardeners.. Section 6.3. Section Summary. Permutations. Combinations. Combinatorial Proofs. Permutations. Definition. : A . permutation. of a set of distinct objects is an ordered arrangement of these objects. An ordered arrangement of r elements of a set is called an . Urn models. We are given set of n objects in an urn (don’t ask why it’s called an “. urn. ” - probably due to some statistician years ago) .. We are going to pick (select) r objects from the urn in. Other Counting Tools: Factorials. MATH 110 Sec 12-3 Lecture: Permutations and Combinations . Other Counting Tools: Factorials. Sometimes we are interested in counting the number of different arrangements of a group of objects.. Therapies in Type 2 Diabetes. DR.M.Mukhyaprana. . Prabhu. Professor of Internal Medicine. Kasturba. Medical College, . Manipal. ,. Manipal. University, India. 2. nd. International Endocrine Conference. 24. th. November 2016. Andrew Gallagher. Consultant Physician. and Endocrinologist. NHS Greater Glasgow & Clyde. Prevalence – 2015 data. WORLDWIDE. . Almost 300 million people with diabetes aged 20-79. Statistics group. Axelborg. 16/01 2012. Anders . Stockmarr,. DTU Data Analysis. Joint work with . Peter Heegaard . and . Nanna Skall Sørensen. Acute Phase Proteins – APP’s:. Proteins whose plasma concentrations . Random Things to Know. Dice. . (singular = “die”). Most cases: 6 sided. Numbers 1,2,3,4,5,6. Special Cases: . 4 sided. 8 sided. 10 sided. 12 sided. 20 sided.  . Random Things to Know. Cards. Typical Deck: 52 cards. Program Goal. Case Presentation: Diane. Case Presentation (cont). ADA/EASD Position Statement. ADA/EASD Position Statement: Glycemic Targets. ADA/EASD Position Statement on Therapeutic Options: Lifestyle. GLP-1 RAs in Combination With Basal Insulin Approved by US FDA. Why Combine a GLP-1 RA With Basal Insulin?. Adding Prandial Insulin to Basal Insulin . Exenatide Once Weekly Now Approved for Use With Basal Insulin. Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator Anna Maria Nardiello. 1,. *, Lucia Sessa. 1,2. , Jacopo Santoro. 1. and Stefano Piotto. 1,2. 1. . Department of Pharmacy, University of Salerno, . Fisciano. , 84084, Italy. 2. . Research. Centre for . Biopsy-Confirmed DIO Mouse Model. JJ Nestor. 1. , K Rigbolt. 2. , M Feigh. 2. , D Parkes. 3. , MS Harris. 1. , 1. Altimmune, Inc., Gaithersburg, MD; 2. Gubra, Horsholm, Denmark; 3. DGP Scientific, Del Mar, CA. Objectives. Discuss the pharmacology of . catecholamines. Classify & describe adrenergic α-agonists including actions, therapeutic uses & adverse. reactions.. Classify & describe adrenergic β-agonists including actions, therapeutic uses & adverse.